Activist Investor Bluebell Takes Stake In GSK

GSK beats expectations, shingles vaccine bolsters outlook

GSK to quit London HQ as healthcare giant pushes ahead with split

Unilever slides and GSK bounces after GSK knocks back £50bn bid

Activist Investor Bluebell Takes Stake in GSK

Activist Hedge Funds: Full Guide

Activist Bluebell Sets Sights on Richemont - Bloomberg

Second hedge fund pushes for change in leadership of GSK, GlaxoSmithKline

Activist Elliott Presses GSK on Progress at Investor Meeting - Bloomberg

Unilever Says GSK Consumer Arm Is A 'Strong Strategic Fit' For Its Business

Fresenius' new CEO signals 'reset' as activist investor circles

Walmsley Targeted Again as Activists Renew Plea for New GSK CEO

GSK banks on stronger offer for its consumer healthcare business, GlaxoSmithKline

A $95b corporate overhaul linking two embattled leaders

Bayer chair wins backing from major shareholder advisory firms -April 14, 2023 at 05:42 am